Safety and Effectiveness of Agilus (Hyaluronic Acid) for Ankle Osteoarthritis

NATerminatedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

December 31, 2008

Conditions
OSTEOARTHRITIS
Interventions
DEVICE

Agilus

Hyaluronic acid (Agilus)given by an intra-articular injection into the ankle for a total of 3 injections for 3 consecutive weeks.

DEVICE

Normal saline

Normal Saline given by an intra-operative injection into the ankle for a total of 3 injections for 3 consecutive weeks.

Trial Locations (19)

14642

University of Rochester, Rochester

19106

University of Pennsylvania, Philadelphia

21202

Institute For Foot and Ankle Reconstruction At Mercy, Baltimore

21218

Greater Chesapeake Orthopaedic Association, Baltimore

28203

Orthocarolina, Charlotte

33411

Pinnacle Research, Royal Palm Beach

43231

Orthopedic Foot and Ankle Center, Columbus

49525

Orthopedic Associates of Grand Rapids, Grand Rapids

55344

Minnesota Sports Medicine, Eden Prairie

60612

Rush University Medical Center, Chicago

65212

University of Missouri, Columbia

77030

Bone and Joint Clinic Houston, Houston

University of Texas Health Science Center At Houston, Houston

89121

Desert Orthopaedic Center, Las Vegas

06032

Orthopaedic Associates of Hartford, Farmington

02115

Brigham Foot and Ankle Center, Boston

03756

Dartmouth Hitchcock Medical Center, Lebanon

07101

UMDNJ, Newark

02903

Rhode Island Hospital, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cartiva, Inc.

INDUSTRY